Spectracef Oral Tablet 200Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Spectracef: Oral tablet (200mg)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file DrugItem_8739.JPG
Spectracef 200mg Tab
Cornerstone Biopharma, a subsidiary of Chiesi USA
Pill Identification: Purdue 200 mg 
Drug Image file DrugItem_3985.JPG
Spectracef 200mg Tab
Cornerstone Biopharma, a subsidiary of Chiesi USA
Pill Identification: Purdue 200 mg 
Drug Image file DrugItem_859.JPG
Spectracef 200mg Tab
TAP Pharmaceuticals Inc, a Takeda Company
Pill Identification: LOGO 200 mg 
Drug Image file DrugItem_10681.JPG
Spectracef 200mg Tab
Methapharm Inc
Pill Identification: CBP 200 
Drug Image file DrugItem_12919.JPG
Cefditoren 200mg Dose Pack Tab
Methapharm Inc
Pill Identification: CBP 200 

What is this Medicine?

CEFDITOREN (sef DIT or in) is a cephalosporin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

In-Depth Information
Select a Medication

Spectracef 200mg Tablet

NDC: 101220801
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pneumonia, Tonsillitis, Skin And Skin Structure Infections, Pharyngitis, Bronchitis, Community-acquired Pneumonia

Storage Information
Protect from light
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Spectracef 200mg Tablet
Drug Image file DrugItem_10681.JPG
Methapharm Inc
Pill Identification: CBP 200 
Shape: oval
Color: white
Ingredients
Close All Sections Show

Reported Side Effects for Spectracef 200mg Tablet

Close Show
Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Causing To Be Hungry Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Low Kidney Function Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Belching Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Kidney Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Vaginal Discharge Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Mouth Sores Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Thirst Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Superinfection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Wheezing Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Vaginal Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Pseudomembranous Colitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Serum Sickness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
>0.1%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
2.0-3.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
11.0-15.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Spectracef

Close Show

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5